U.S. markets open in 1 hour 6 minutes
  • S&P Futures

    3,720.50
    +50.50 (+1.38%)
     
  • Dow Futures

    29,669.00
    +326.00 (+1.11%)
     
  • Nasdaq Futures

    11,498.50
    +182.25 (+1.61%)
     
  • Russell 2000 Futures

    1,689.00
    +26.50 (+1.59%)
     
  • Crude Oil

    77.89
    +1.18 (+1.54%)
     
  • Gold

    1,644.70
    +11.30 (+0.69%)
     
  • Silver

    18.67
    +0.19 (+1.06%)
     
  • EUR/USD

    0.9649
    +0.0037 (+0.39%)
     
  • 10-Yr Bond

    3.8780
    0.0000 (0.00%)
     
  • Vix

    30.99
    +1.07 (+3.58%)
     
  • GBP/USD

    1.0794
    +0.0111 (+1.04%)
     
  • USD/JPY

    144.4920
    -0.1880 (-0.13%)
     
  • BTC-USD

    20,316.78
    +1,441.22 (+7.64%)
     
  • CMC Crypto 200

    463.96
    +30.86 (+7.13%)
     
  • FTSE 100

    7,038.70
    +17.75 (+0.25%)
     
  • Nikkei 225

    26,571.87
    +140.32 (+0.53%)
     

USD 255.58 Mn growth opportunity in Femoral Stems Market -- North America to generate maximum revenue

·13 min read

NEW YORK, Sept. 19, 2022 /PRNewswire/ -- The "Femoral Stems Market by Type and Geography - Forecast and Analysis 2022-2026" report by Technavio expects the market to observe significant growth in North America. The high prevalence of orthopedic disorders and related risk factors are creating huge growth opportunities for vendors operating in the region. According to the report, the market will observe an incremental growth of USD 255.58 million between 2021 and 2026, accelerating at a CAGR of 5.265 during the forecast period.

Technavio has announced its latest market research report titled Global Femoral Stems Market 2022-2026
Technavio has announced its latest market research report titled Global Femoral Stems Market 2022-2026

Get detailed insights into the market size, regional opportunities, YOY growth rates, competitive landscape, and other important statistics. Buy Full Report Now

Our femoral stems market report covers the following areas:

The market is fragmented due to the presence of many players. Vendors in the market are engaged in M&As and collaborations with other vendors to develop innovative technologies and remain competitive. They are also focusing on differentiating their products and services based on device quality, the accuracy of results, and associated value-added services. Some of the key players identified in the market study include Akcome Medical Holdings Co. Ltd., Altimed JSC, Amplitude SAS, B. Braun SE, Beijing Chunlizhengda Medical Instruments Co. Ltd., BEZNOSKA Sro, Biotechni SAS, Corentec Co. Ltd., EVOLUTIS SAS, Exactech Inc., GROUP FH ORTHO, Gruppo Bioimpianti Srl, IMECO SA, ImplanTec GmbH, Johnson and Johnson, Lepine Group, Limacorporate Spa, Medacta Group SA, Meril Life Sciences Pvt. Ltd., PETER BREHM GmbH, Smith and Nephew plc, Stryker Corp., X.NOV, and Zimmer Biomet Holdings Inc.

The market is driven by the increasing prevalence of OA. The prevalence of orthopedic diseases such as osteoporosis, RA, and OA is increasing worldwide. For instance, in 2017, more than 30 million adults in the US had OA. Between 2011 and 2025, the prevalence of OA is expected to increase to 375.55 million cases globally. Besides, the rise in average life expectancy has resulted in an increase in the global geriatric population. All these factors are contributing to the growth of the global femoral stems market during the forecast period.

In addition, the increasing number of hip replacement surgeries and advances in femoral stems will offer immense growth opportunities. However, the high cost of hip replacement surgeries and declining reimbursements will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The global femoral stems market is segmented as below:

  • Type

  • Geography

Femoral Stems Market 2022-2026: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the femoral stems market, including some of the dominant vendors. Backed with competitive intelligence and benchmarking, our research report on the femoral stems market is designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support. Request Sample Report Here

Femoral Stems Market 2022-2026: Key Highlights

  • CAGR of the market during the forecast period 2022-2026

  • Detailed information on factors that will assist femoral stems market growth during the next five years

  • Estimation of the femoral stems market size and its contribution to the parent market

  • Predictions on upcoming trends and changes in consumer behavior

  • The growth of the femoral stems market

  • Analysis of the market's competitive landscape and detailed information on vendors

  • Comprehensive details of factors that will challenge the growth of femoral stems market vendors

Related Reports:

Femoral Stems Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 5.26%

Market growth 2022-2026

USD 255.58 million

Market structure

Fragmented

YoY growth (%)

4.19

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 49%

Key consumer countries

US, Germany, France, China, and Japan

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Akcome Medical Holdings Co. Ltd., Altimed JSC, Amplitude SAS, B. Braun SE, Beijing Chunlizhengda Medical Instruments Co. Ltd., BEZNOSKA Sro, Biotechni SAS, Corentec Co. Ltd., EVOLUTIS SAS, Exactech Inc., GROUP FH ORTHO, Gruppo Bioimpianti Srl, IMECO SA, ImplanTec GmbH, Johnson and Johnson, Lepine Group, Limacorporate Spa, Medacta Group SA, Meril Life Sciences Pvt. Ltd., PETER BREHM GmbH, Smith and Nephew plc, Stryker Corp., X.NOV, and Zimmer Biomet Holdings Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table Of Contents:

1 Executive Summary

  • 1.1 Market overview

2 Market Landscape

  • 2.1 Market ecosystem

3 Market Sizing

  • 3.1 Market definition

  • 3.2 Market segment analysis

  • 3.3 Market size 2021

  • 3.4 Market outlook: Forecast for 2021-2026

4 Five Forces Analysis

  • 4.1 Five forces summary

  • 4.2 Bargaining power of buyers

  • 4.3 Bargaining power of suppliers

  • 4.4 Threat of new entrants

  • 4.5 Threat of substitutes

  • 4.6 Threat of rivalry

  • 4.7 Market condition

5 Market Segmentation by Type

  • 5.1 Market segments

  • 5.2 Comparison by Type

  • 5.3 Cementless femoral stems - Market size and forecast 2021-2026

  • 5.4 Cemented femoral stems - Market size and forecast 2021-2026

  • 5.5 Market opportunity by Type

6 Customer Landscape

  • 6.1 Customer landscape overview

7 Geographic Landscape

  • 7.1 Geographic segmentation

  • 7.2 Geographic comparison

  • 7.3 North America - Market size and forecast 2021-2026

  • 7.4 Europe - Market size and forecast 2021-2026

  • 7.5 Asia - Market size and forecast 2021-2026

  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026

  • 7.7 US - Market size and forecast 2021-2026

  • 7.8 Germany - Market size and forecast 2021-2026

  • 7.9 France - Market size and forecast 2021-2026

  • 7.10 China - Market size and forecast 2021-2026

  • 7.11 Japan - Market size and forecast 2021-2026

  • 7.12 Market opportunity by geography

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers

  • 8.2 Market challenges

  • 8.3 Impact of drivers and challenges

  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview

  • 9.2 Vendor landscape

  • 9.3 Landscape disruption

  • 9.4 Industry risks

10 Vendor Analysis

  • 10.1 Vendors covered

  • 10.2 Market positioning of vendors

  • 10.3 Akcome Medical Holdings Co. Ltd.

  • 10.4 Amplitude SAS

  • 10.5 B. Braun SE

  • 10.6 Beijing Chunlizhengda Medical Instruments Co. Ltd.

  • 10.7 Biotechni SAS

  • 10.8 Corentec Co. Ltd.

  • 10.9 Johnson and Johnson

  • 10.10 Smith and Nephew plc

  • 10.11 Stryker Corp.

  • 10.12 Zimmer Biomet Holdings Inc.

11 Appendix

  • 11.1 Scope of the report

  • 11.2 Inclusions and exclusions checklist

  • 11.3 Currency conversion rates for US$

  • 11.4 Research methodology

  • 11.5 List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Global Femoral Stems Market 2022-2026
Global Femoral Stems Market 2022-2026
Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/usd-255-58-mn-growth-opportunity-in-femoral-stems-market--north-america-to-generate-maximum-revenue-301626544.html

SOURCE Technavio